Author: Ando Kosei Mori Kanji Corradini Nedège Redini Françoise Heymann Dominique
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.12, Iss.2, 2011-02, pp. : 285-292
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mifamurtide: A Review of its Use in the Treatment of Osteosarcoma
Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. :
Mifamurtide boosts chemo efficacy in osteosarcoma
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 608, 2010-01 ,pp. :
Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment
Current Pharmaceutical Design, Vol. 21, Iss. 36, 2015-11 ,pp. :
Mifamurtide receives positive opinion in Europe.
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :